Illinois Featured Content

  • Human trials of cancer drug PAC-1 continue with new investment

    May 24, 2016 1:00 pm by Diana YatesResearch
    Illinois chemistry professor Paul Hergenrother and veterinary clinical medicine professor Timothy Fan

    Images

    • Illinois chemistry professor Paul Hergenrother and veterinary clinical medicine professor Timothy Fan

    The FDA also granted PAC-1 orphan drug status for the treatment of glioblastoma multiforme, a deadly brain cancer. Some steps in the approval process are aided or expedited for orphan drugs.